Kaplan, H. Et Al. 2023. Is the C-reactive protein-to-albumin ratio the most remarkable simple inflammatory marker showing active disease in patients with axial spondyloarthritis, psoriatic arthritis, and rheumatoid arthritis?. CLINICAL RHEUMATOLOGY , vol.00, no.00 .

Kaplan, H., Cengiz, G., Şaş, S., & Eldemir, Y. Ö., (2023). Is the C-reactive protein-to-albumin ratio the most remarkable simple inflammatory marker showing active disease in patients with axial spondyloarthritis, psoriatic arthritis, and rheumatoid arthritis?. CLINICAL RHEUMATOLOGY , vol.00, no.00.

Kaplan, HÜSEYİN Et Al. "Is the C-reactive protein-to-albumin ratio the most remarkable simple inflammatory marker showing active disease in patients with axial spondyloarthritis, psoriatic arthritis, and rheumatoid arthritis?," CLINICAL RHEUMATOLOGY , vol.00, no.00, 2023

Kaplan, HÜSEYİN Et Al. "Is the C-reactive protein-to-albumin ratio the most remarkable simple inflammatory marker showing active disease in patients with axial spondyloarthritis, psoriatic arthritis, and rheumatoid arthritis?." CLINICAL RHEUMATOLOGY , vol.00, no.00, 2023

Kaplan, H. Et Al. (2023) . "Is the C-reactive protein-to-albumin ratio the most remarkable simple inflammatory marker showing active disease in patients with axial spondyloarthritis, psoriatic arthritis, and rheumatoid arthritis?." CLINICAL RHEUMATOLOGY , vol.00, no.00.

@article{article, author={HÜSEYİN KAPLAN Et Al. }, title={Is the C-reactive protein-to-albumin ratio the most remarkable simple inflammatory marker showing active disease in patients with axial spondyloarthritis, psoriatic arthritis, and rheumatoid arthritis?}, journal={CLINICAL RHEUMATOLOGY}, year=2023}